Wavu Wank

TEKKEN® 8 glicko2 Ratings &
Online Ranked Statistics
エボルブボディ望月

Ratings

エボルブボディ望月 vs Armor King 32–39 45.07%
エボルブボディ望月 vs Jin 34–21 61.82%
エボルブボディ望月 vs Kazuya 28–27 50.91%
エボルブボディ望月 vs Steve 28–22 56.00%
エボルブボディ望月 vs Bryan 26–20 56.52%
エボルブボディ望月 vs Paul 24–21 53.33%
エボルブボディ望月 vs Dragunov 22–23 48.89%
エボルブボディ望月 vs Hwoarang 23–21 52.27%
エボルブボディ望月 vs Anna 31–10 75.61%
エボルブボディ望月 vs Asuka 18–18 50.00%
エボルブボディ望月 vs Reina 21–15 58.33%
エボルブボディ望月 vs Law 18–17 51.43%
エボルブボディ望月 vs Leroy 17–18 48.57%
エボルブボディ望月 vs Xiaoyu 18–16 52.94%
エボルブボディ望月 vs Heihachi 16–18 47.06%
エボルブボディ望月 vs Jack-8 11–22 33.33%
エボルブボディ望月 vs King 22–10 68.75%
エボルブボディ望月 vs Fahkumram 20–10 66.67%
エボルブボディ望月 vs Claudio 17–11 60.71%
エボルブボディ望月 vs Lars 15–12 55.56%
エボルブボディ望月 vs Lidia 16–10 61.54%
エボルブボディ望月 vs Eddy 13–10 56.52%
エボルブボディ望月 vs Yoshimitsu 12–10 54.55%
エボルブボディ望月 vs Lili 12–10 54.55%
エボルブボディ望月 vs Jun 14–8 63.64%
エボルブボディ望月 vs Feng 9–12 42.86%
エボルブボディ望月 vs Lee 10–10 50.00%
エボルブボディ望月 vs Miary Zo 10–10 50.00%
エボルブボディ望月 vs Clive 8–11 42.11%
エボルブボディ望月 vs Victor 5–11 31.25%
エボルブボディ望月 vs Azucena 8–7 53.33%
エボルブボディ望月 vs Raven 9–5 64.29%
エボルブボディ望月 vs Kuma 7–6 53.85%
エボルブボディ望月 vs Devil Jin 6–6 50.00%
エボルブボディ望月 vs Nina 4–8 33.33%
エボルブボディ望月 vs Shaheen 6–3 66.67%
エボルブボディ望月 vs Zafina 2–7 22.22%
エボルブボディ望月 vs Leo 5–3 62.50%
エボルブボディ望月 vs Alisa 3–2 60.00%
エボルブボディ望月 vs Panda 2–2 50.00%

Limitations

This data is often requested to give insight into which characters you have more trouble with than others, but it is not particularly helpful for that. The main issue is that it is heavily skewed by how strong the opponents you play are.

For example, this data suggests my worst matchup is clearly vs Reina, but that's just because most of those games are vs Yagami.

There is a way to account for this being worked on. The central idea is to assign each matchup a rating vs you which adjusts based on the result, much like the regular rating but also based on the rating of each player. With this, it would give a better summary of how well you perform vs each character.

In the meantime, this page is here to present the data as requested.